Home › Funds › PSP Research LLC › NRIX

PSP Research LLC position in NRIX

NURIX THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 12,000 shares of NRIX (NURIX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$285K, representing 0.20% of its reported portfolio and ranking #9 among its reported holdings. PSP Research LLC has disclosed NRIX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)12.00K sh
Reported value held$284.52K
Portfolio Weight0.20%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's NRIX position evolved

PSP Research LLC first disclosed a stake in NRIX in Q4 2025 at 28,713 shares (US$545K). The position peaked in Q2 2026 at 25,000 shares, worth US$606K. Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$285K — a reduction of -13,000 shares quarter over quarter.. Notable position changes include a 52% trim in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 28.71K $544.69K New
Q1 2026 28.70K $444.85K Hold
Q2 2026 25.00K $606.50K Reduce
Q3 2026 12.00K $284.52K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has PSP Research LLC held NRIX?

PSP Research LLC has disclosed NRIX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in NRIX?

As of Q3 2026, PSP Research LLC holds 12.00K shares of NRIX (NURIX THERAPEUTICS INC), valued at $284.52K, representing 0.20% of its reported portfolio and ranking #9.

Has PSP Research LLC been buying or selling NRIX?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in NRIX. The position peaked in Q2 2026 at 25.00K shares.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.